Topic: Yesterday, Rubean announced a rather conservative topline guidance for FY24 as well as an ambitious mid-term vision with regards to sales, EBIT and app user. In detail:

Sales to more than double in FY24. Rubean is expecting to grow its sales by 135% at mid-point to € 2.2-2.5m in FY24. On the back of the recently announced cooperations paired further likely customer wins, we consider this guidance as rather conservative, still anticipating € 3.0m sales (eNuW). As it is difficult to precisely forecast the exponential growth trajectory, management seems to play it safe.

40+% EBIT margin by FY27. For FY27, Rubean is aiming for € 10+m in sales, implying a 78% CAGR 2023-27e, which is even above our estimates of € 9.0m. As we see Rubean at the forefront of the rapidly growing market for mobile payment acceptance systems that is just at the beginning, the vision looks reasonable. Thanks to scale effects of the highly scalable business model, management is guiding for 40+% EBIT margin in FY27, which is in line with our estimates (eNuW: 41%).

1m app user until 2025. Further, management is expecting 1m app user until 2025 after having reported 25k in FY23. While we think that this figure is a bit too ambitious (eNuW: 350k, only reflecting the user potential of existing contracts), it is not completely out of reach, as a single major contract could completely change the picture.

Following the recent series of important strategic partnerships within a short period of time (i.e. Global Payments, Correos, emerchantpay), Rubean is showing once again very clearly that its leading softPOS product is ready and that the roll-out is in full swing. Furthermore, many of the initial pilot projects of earlier won customers went into regular operations, generating revenues. Among these customers are national postal services such as GLS in Spain, DPD, Express One or Dodo in Eastern Europe but also large banks such as BBVA in Spain and Global Payments Europe. In our view, more positive newsflow from further new partnerships within FY24 that should further ramp-up sales and EBIT going forward, is likely, helping to beat the guidance.

BUY with an unchanged PT of € 9.00, based on our DCF.